HINTEGRA Total Ankle Prosthesis Follow-up
Short to Mid Term Follow-up of Patient Implanted With the HINTEGRA® Total Ankle Prosthesis
1 other identifier
observational
225
6 countries
6
Brief Summary
The Hintegra® Total Ankle Prosthesis is a non constrained, three-component prosthesis that consists of a flat tibial component, an anatomically-shaped talar component, and a high-density polyethylene inlay. The Hintegra ankle was specifically developed as an attempt to address the needs of minimal bone resection, extended bone support, proper ligament balancing, and minimal contact stressed within and around the prosthesis. The objective of this study is to evaluate the safety and efficacy of the HINTEGRA® Total Ankle prosthesis at short and mid term follow up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2009
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 26, 2011
CompletedFirst Posted
Study publicly available on registry
January 27, 2011
CompletedOctober 10, 2012
October 1, 2012
1.8 years
January 26, 2011
October 9, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
rate of device related complications at the follow up after 2 years of implantation
more than 2 years after the implantation
Secondary Outcomes (1)
AOFAS Ankle-Hindfoot Scale score (American Orthopaedic Foot and Ankle Society).
more than 2 years after the implantation
Study Arms (1)
HINTEGRA
Patient Implanted with the HINTEGRA Total Ankle Prosthesis more than 2 years ago
Eligibility Criteria
Patient implanted with an Hintegra® Total Ankle Prosthesis (only prosthesis designed with pegs) in primary ankle surgery since a minimum of 2 years
You may qualify if:
- Patient implanted with an Hintegra® Total Ankle Prosthesis (only prosthesis designed with pegs) in primary ankle surgery since a minimum of 2 years
- Age ≥ 18 years
- Have willingness to give his/her data transfer authorisation
You may not qualify if:
- History of prior mental illness or patient demonstrates that their mental capacity may interfere with their ability to follow the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Medical University of Innsbruck
Innsbruck, A-6020, Austria
St. Michael's Hospital
Toronto, M5C 1R6, Canada
CHU d'Amiens - Hopital Nord
Amiens, 80054, France
AukammKlinik
Wiesbaden, 65191, Germany
Severance Hospital - Yonsei University
Seoul, South Korea
Hopital San Rafael
Barcelona, 08035, Spain
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2011
First Posted
January 27, 2011
Study Start
February 1, 2009
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
October 10, 2012
Record last verified: 2012-10